WinstonWınston
Back
Sikarin Public Company Limited logo

Sikarin Public Company Limited

SKR.BK
51
Medical - Care Facilities · Healthcare
Exchange
Stock Exchange of Thailand
Winston Score
51
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Exceptional
Stability
Exceptional
Valuation
Mixed
Dividends
Strong

Winston Score History

The full picture

Sikarin Public Company Limited is a Thai private hospital operator based in Bangkok, Thailand. It runs Sikarin Hospital, a full-service medical facility offering inpatient and outpatient care, surgery, specialist consultations, and diagnostic services. The hospital primarily serves middle- to upper-income Thai patients as well as medical tourists, mainly from neighboring countries in Southeast Asia.

The company earns money by charging patients for hospital stays, medical procedures, doctor visits, and ancillary services like lab tests and pharmacy sales. It operates within Thailand's private healthcare sector, which benefits from an aging population and growing demand for quality medical care beyond the public system. With a market capitalization of roughly 16 billion Thai baht, Sikarin is a mid-sized player competing against larger hospital groups like Bumrungrad and Bangkok Dusit Medical Services. The key growth driver is rising healthcare spending among Thailand's growing middle class, while the main risk is intense competition from better-resourced hospital networks that can attract top medical talent and international patients more aggressively.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
28.2%
Modest — 28.2% gross margin
Profit after running costs
Operating Margin
13.5%
Healthy — 13.5% operating margin
Return on the money invested
ROCE
9.4%
Below par — 9.4% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-5.7%
Shrinking sales (-5.7% YoY)
Profit growth
EPS YoY
-8.9%
Earnings shrinking (-8.9% YoY)

Slight earnings drop. Typical near a cyclical low.

How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
227%
Turns 227% of profit into real cash
Spare cash per sale
FCF Margin
16.9%
Converts sales into free cash efficiently (16.9%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.05
Conservative — low debt load (0.05)
Covers its interest
Interest Cover
32.41x
Comfortably covers interest (32.4x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
26.2x
no trend
Growth-priced — P/E 26.2

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
3.13%
no trend
Moderate income — 3.13% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+32.4%
no trend
Dividend growing fast (32.4% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial